HISTORY
HORUS PHARMA
The history of Horus Pharma reflects its founders’ taste for business and passion for ophthalmology: Martine and Claude Claret, two Doctors of Pharmacy with complementary expertise in R&D and business development.
Founded in 2003, Horus Pharma successfully established itself among key players in ophthalmology in France and around the world.
Horus Pharma continues its growth, combining flexibility with a family business approach. The company has been driven by international expansion and sustained growth for 20 years.
Passion and expertise for ophthalmology has led to entrepreneurial success.
KEY DATES
Founded
Founded at Saint-Laurent du Var (postal code 06), Horus Pharma obtains its status as a pharmaceutical establishment in 2003. The laboratory focuses its business on distributing third-party products.
“preservative-free"
Horus Pharma solidifies its status as a pioneer in the “preservative-free" market by obtaining the first reimbursement by Social Security for eye drops formulated with hyaluronic acid.
Specialists
Horus Pharma expands its portfolio by incorporating new specialities developed by the laboratory, including medicinal products and medical devices, packaged in preservative-free single-dose units.
Associative
Horus Pharma co-founds and chairs Ophta Biotech, an association that brings together actors in ophthalmology and patient associations in the Mediterranean arc.
Europe
The Export strategy kicks off in Europe with the signing of the first distribution agreements with Germany, Switzerland and Austria. To support its international expansion, Horus Pharma incorporates Edel Pharma, a company specialised in Business Development.
1st subsidiary
The laboratory’s first European subsidiary is founded in 2015 with the creation of Horus Iberica, based in Bilbao, Spain.
3rd subsidiary
The third European subsidiary of the laboratory is established in 2017 in the Netherlands.
amniotic membranes
Launch of the 1st European lyophilized amniotic membranes in Europe.
Awards
Launch of Iluvien. Women Equity award 2019.
Glaucoma
Launch of innovative treatments for glaucoma.
International growth
Opening of our subsidiary in Switzerland.
Scandinavia
Opening of Horus Pharma Scandinavia. Located in Stockholm, the subsidiary covers Sweden, Norway, Finland, and Denmark.
AN AWARD-WINNING ENTREPRENEURIAL RECORD
TRIBUNE WOMEN AWARDS
PACA Region
ETIENNE MARCEL AWARD
for the CSR approach initiated by the laboratory
ENTREPRENEUR OF THE YEAR AWARD, INNOVATION IN THE MEDITERRANEAN REGION
awarded to Martine and Claude Claret.
WOMEN'S INNOVATIVE ECONOMY AWARD
PACA, tildelt Martine Claret, CEO for Horus Pharma.
NATIONAL GRAND PRIX DEVELOPMENT AND GROWTH POTENTIAL
Grand Prix for Growing Companies.
NATIONAL WOMEN EQUITY AWARD "ECONOMIC PERFORMANCE"
awarded to Martine Claret for Horus Pharma's growth and dynamism, a French company managed by a woman.
NATIONAL WOMEN'S EQUITY AWARD "CSR PERFORMANCE"
awarded to Martine Claret
The tenth edition of the Women Equity Awards
has just rewarded the 50 most successful French companies run by women. Horus Pharma is one of the winning companies.
FWE40
French Women Equity Martine Claret is elected Laureate by the FWE40.
